Page last updated: 2024-08-26

artesunic acid and Proteinuria

artesunic acid has been researched along with Proteinuria in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	1 (33.33)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Chen, Q; Chen, Z; Guo, Y; Huo, Y; Li, H; Li, S; Liu, L; Lv, J; Shen, C; Sun, W; Wang, Z; Zhou, J	1
Li, YH; Wan, RJ	1
Gu, Z; Jiang, B; Jin, O; Sun, L; Wang, J; Xu, T; Zeng, X; Zhang, H; Zhao, S; Zhou, K	1

Trials

1 trial(s) available for artesunic acid and Proteinuria

Article	Year
Efficacy and safety of artesunate for patients with IgA nephropathy: a study protocol for a multicenter, double-blind, randomized, placebo-controlled trial. Trials, 2022, May-25, Volume: 23, Issue:1 Topics: Artesunate; Double-Blind Method; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Multicenter Studies as Topic; Proteinuria; Randomized Controlled Trials as Topic	2022

Other Studies

2 other study(ies) available for artesunic acid and Proteinuria

Article	Year
Effects of Artesunate prevent nephritis via the Toll‑like receptor 4/nuclear factor‑κB signaling pathway in rats. Molecular medicine reports, 2017, Volume: 16, Issue:5 Topics: Actins; Administration, Oral; Animals; Anti-Inflammatory Agents; Artemisinins; Artesunate; Biphenyl Compounds; Carbamates; Female; Gene Expression Regulation; Interleukin-6; Kidney; Kidney Function Tests; Mice; Mice, Inbred BALB C; Myeloid Differentiation Factor 88; Nephritis; Niacinamide; Proteinuria; Pyrazoles; Signal Transduction; Toll-Like Receptor 4; Transcription Factor RelA; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha	2017
A pilot study of the therapeutic efficacy and mechanism of artesunate in the MRL/lpr murine model of systemic lupus erythematosus. Cellular & molecular immunology, 2009, Volume: 6, Issue:6 Topics: Animals; Antibodies, Antinuclear; Artemisinins; Artesunate; B-Cell Activating Factor; Body Weight; Chemokine CCL2; Disease Models, Animal; Female; Gene Expression Regulation; Leukocytes; Lupus Erythematosus, Systemic; Mice; Pilot Projects; Proteinuria	2009

Article

Year

Effects of Artesunate prevent nephritis via the Toll‑like receptor 4/nuclear factor‑κB signaling pathway in rats.

Molecular medicine reports, 2017, Volume: 16, Issue:5

Topics: Actins; Administration, Oral; Animals; Anti-Inflammatory Agents; Artemisinins; Artesunate; Biphenyl Compounds; Carbamates; Female; Gene Expression Regulation; Interleukin-6; Kidney; Kidney Function Tests; Mice; Mice, Inbred BALB C; Myeloid Differentiation Factor 88; Nephritis; Niacinamide; Proteinuria; Pyrazoles; Signal Transduction; Toll-Like Receptor 4; Transcription Factor RelA; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha

2017

A pilot study of the therapeutic efficacy and mechanism of artesunate in the MRL/lpr murine model of systemic lupus erythematosus.

Cellular & molecular immunology, 2009, Volume: 6, Issue:6

Topics: Animals; Antibodies, Antinuclear; Artemisinins; Artesunate; B-Cell Activating Factor; Body Weight; Chemokine CCL2; Disease Models, Animal; Female; Gene Expression Regulation; Leukocytes; Lupus Erythematosus, Systemic; Mice; Pilot Projects; Proteinuria

2009